PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, ...
Moby summary of Stevanato Group S.p.A.'s Q4 2025 earnings call ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results